Platelet Survival Studies in Man with Diisopropylphosphorofluoridate (DF32P). SOME OBSERVATIONS IN PATIENTS WITH HYPOCOAGULABILITY, ‘HYPERCOAGULABILITY’ AND PLATELET DISORDERS *

P. Barkhan
DOI: https://doi.org/10.1111/j.1365-2141.1966.tb00122.x
1966-01-01
British Journal of Haematology
Abstract:Diisopropylphosphorofluoridate (DF32P) acts as a cell label by combining irreversibly with esterases in the cell membrane. It was first used in man for tagging red cells (Cohen and Warringa, 1954) and later for platelets (Leeksma and Cohen, 1956) and leucocytes (Athens, Mauer, Ashenbrucker, Cartwright and Wintrobe, 1959). Since DF32P allows platelets to be labelled directly in vivo it has obvious advantages over the 51Cr method (Aas and Gardner, 1958) which necessitates removal of platelets from the body for labelling and subsequent re‐injection.
What problem does this paper attempt to address?